Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Comprehensive profiling of AML and T-cell states across disease stages in acute myeloid leukemia using spectral flow cytometry.
Journal: Blood immunology & cellular therapy
Published: May 11, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.
Journal: JCO precision oncology
Published: April 23, 2026
RAS-ing the bar in the treatment of KRAS-mutant cholangiocarcinoma.
Journal: Cancer cell
Published: March 31, 2026
Cancer Chemoimmunotherapy: Time Will Tell.
Journal: Cancer immunology research
Published: March 18, 2026
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 01, 2026
Utilizing machine learning to identify multimodal signatures for patients who would benefit from the addition of tremelimumab to durvalumab and chemotherapy (TRIDENT).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 14, 2025
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: October 30, 2025
Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study.
Journal: Therapeutic advances in medical oncology
Published: May 01, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 24, 2025
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary.
Journal: Future oncology (London, England)
Published: March 25, 2025
Last Updated: 09/26/2026